RAD21 and acute myeloid leukemia: Finally, the comparative analysis of the ASXL1 mutation and RAD21 methylation data in our cohort of AML patients revealed similar frequencies of methylation between ASXL1 mutated and ASXL1 wild-type samples (23.3% and 26.7%, respectively).